FDA Adverse Event Injury Summary report: N

XEN 45 GTS

MDR report key: 8797678 · Received July 17, 2019

Report

Report Number
3011299751-2019-00162
Event Type
Injury
Date Received
July 17, 2019
Date of Event
March 5, 2019
Report Date
March 4, 2020
Manufacturer
ALLERGAN (IRVINE)
Product Code
KYF
PMA / PMN Number
K161457
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

A REVIEW OF THE DEVICE HISTORY RECORD HAS BEEN INITIATED. IF ANY DEVIATIONS OR NON-CONFORMANCES ARE FOUND, A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED.

Description of Event or Problem · 0

ADDITIONAL INFORMATION NOTED LEFT EYE VISUAL IS LIGHT PERCEPTION WITH CONJUNCTIVA SEVERELY INFECTED AND DEVICE COULD NOT BE SEEN AT THE PARS PLANA VITRECTOMY. TREATMENT WAS NOTED AS VITRECTOMY WITH ANTIBIOTICS. THE EVENT HAS NOT BEEN RESOLVED.

Additional Manufacturer Narrative · 1

THE REPORTED EVENTS OF ENDOPHTHALMITIS, BLEBITIS AND VISION LOSS ARE PHYSIOLOGICAL COMPLICATIONS AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THESE EVENTS. FURTHER INFORMATION FROM THE REPORTER REGARDING THE PRODUCT, AND PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THIS IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.

Description of Event or Problem · 1

HEALTHCARE PROFESSIONAL REPORTED SEVERE ENDOPHTHALMITIS/BLEBITIS ABOUT 9 MONTH POST-OP IN THE LEFT EYE WITH VISION FROM 0,3 TO 1/20 NTV. PATIENT HAS BEEN TREATED WITH EXCISION OF BLEB, PPV (PAR PLANA VITRECTOMY) AND EXPLANTATION OF THE LENS. THE DEVICE REMAINS IMPLANTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
591211 XEN 45 GTS IMPLANT, EYE VALVE KYF ALLERGAN (IRVINE) 62066

Patients

Seq Age Sex Outcome Treatment
1 84 YR Required Intervention